Abstract:Objective To study on the feasibility of enhancing the anti-tumor effect of suicide gene therapy using herpes simplex virus thymidine kinase/gancyclovir (HSV-tk/GCV) system for malignant gliomas by connexin43 (Cx43) gene.Methods C6 rat glioma cells cotransfected in vitro with lipofectamine-mediated Cx43 cDNA and adenovirus-mediated HSV-tk gene were exposed to ganciclovir (GCV) with different concentrations and MMT assay was applied to detect the survival rate of cells.Then the rat models were established by in vivo injection of C6 rat glioma cells into the tight caudate nucleus of Sprague-Dawley (SD) rats.Cx43 and HSV-tk genes were injected in situ and GCV was injected intraperitoneally;the survival time of all the tumor-bearing rats were observed;dynamic contrast-enhanced MRI was used to monitor the size of gliomas in tumor-bearing rats;in situ hybridization assay was used to detect the expressions of Cx43 and HSV-tk genes;and,TUNEL assay was used to detect apoptosis ofglioma cells.Results Cx43 evidently improved the anti-tumor effect of HSV-tk/GCV system on gliomas in vivo and in vitro by enhancing the bystander effect when about 50% of C6 glioma cells were transfected with tk gene.The concentration of GCV for ID_(50) and ID_(100) of C6 cells cotransfected with Cx43 cDNA and HSV-tk gene was 10 times lower than that transfected with HSV-tk gene alone.In vivo study:rats beating C6 gliomas treated by Cx43 gene transduction and HSV-tk/GCV system had evidently prolonged survival time (P<0.001) and higher apoptotic rate compared to those treated by HSV-tk/GCV alone.Contrast-enhanced MRI showed that intracranial tumors of three tumor-bearing rats disappeared within eight weeks.Conclusion Cx43 gene transduction significantly enhances the bystander effect of HSV-tk/GCV gene therapy.The combination of HSV-tk/GCV system with Cx43 gene transduction may be optimal for clinical therapeutic trials of gene therapy for malignant gliomas.

Combined Therapy of Suicide Gene and Cytokine Gene for Cancer

Current Progress in Suicide Gene Therapy for Cancer

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

TK Gene Combined with Mil-2 and Mgm-Csf Genes in Treatment of Gastric Cancer

Mechanism Research of HSV-TK/GCV System on Tumor Gene Therapy

The Effects of HSV-TK/GCV Suicide Gene Therapy System on Human Pancreatic Cancer Cells

[Experimental Studies on the Characteristics of Suicide Gene System HSV-tk/GCV and Its Effect on Dendritic Cells].

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.

Experimental study on the anti-malignant glioma effect of HSV-tk/GCV suicide gene therapy system enhanced by Cx43 gene

Improving the safety of cell therapy with the TK-suicide gene

Co-expression of Suicide gene Promotes the Apoptosis of HepG2 Cells

Anti-hepatoma effect of suicide gene therapy using HSV/TK combined with ganciclovir in hepatoma cells

Killing effects of combination of cytosine deaminase and HSV-tk genes on SW1990 cells mediated by retroviral vector

Enhancements on HSV-tk/GCV Cancer Suicide Gene Therapy System

[Toxic Effects of HSV-TK and CD-TK Suicidal Gene Systems on Prostate Carcinoma Cells].

Enhanced antitumor effects of suicide gene therapy by simultaneous transfer of GM-CSF gene in leukemia-bearing mice

Killing Effects of Cytosine Deaminase and HSV-tk Double Suicide Genes on K562 Cells Mediated by Retrovirus Vector

In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line

Combination of Suicide Gene and Interleukin 2 Gene Transfer Elicited Potent Antitumor Effects on Murine Melanoma

In Vivo and in Vitro Experimental Study on Cervix Cancer with Combination of HSV-TK/GCV Suicide Gene Therapy System and 60 Co Radiotherapy

Hsv-Tk/Gcv Gene Therapy Mediated By Ebv-Lmpi For Ebv-Associated Cancer